NAMPT small-molecule inhibitors were shown to induce cytotoxicity through NAD+ depletion in a wide range of tumor models in vitro and in vivo (e.g., colorectal carcinoma, acute myeloid leukemia and glioblastoma) [26]. The gene discussed is NAMPT; the disease is glioblastoma.